Chemomab Therapeutics Ltd. Accrued Liabilities, Current
Chemomab Therapeutics Ltd. (CMMB) had Accrued Liabilities, Current of $337.00 thousand as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-03-23
- 2025-12-31: Accrued Liabilities, Current $337.00K.
- 2025-06-30: Accrued Liabilities, Current $666.00K.
- 2024-12-31: Accrued Liabilities, Current $1.54M; Accrued Liabilities, Current as first filed $1.56M.
- 2024-06-30: Accrued Liabilities, Current $2.55M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $337.00K 20-F · filed 2026-03-23 | |
| 2025-06-30 | $666.00K 6-K · filed 2025-08-14 | |
| 2024-12-31 | $1.54M 20-F · filed 2026-03-23 | $1.56M 20-F · filed 2025-04-04 |
| 2024-06-30 | $2.55M 6-K · filed 2024-08-21 | |
| 2023-12-31 | $3.42M 20-F · filed 2025-04-04 | |
| 2023-06-30 | $2.50M 6-K · filed 2023-08-14 | |
| 2023-03-31 | $3.16M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.38M 20-F · filed 2024-03-28 | |
| 2022-09-30 | $2.58M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $1.71M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $1.25M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $555.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $637.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $977.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.96M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $715.00K 10-K · filed 2022-03-30 | $1.46M 10-K · filed 2021-03-09 |
| 2020-09-30 | $1.36M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $352.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $935.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $372.00K 10-K · filed 2021-03-09 | $2.20M 10-K · filed 2020-03-17 |
| 2018-12-31 | $1.62M 10-K · filed 2020-03-17 |